We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$14.8B
AUM Growth
+$674M
Cap. Flow
-$313M
Cap. Flow %
-2.12%
Top 10 Hldgs %
30.84%
Holding
634
New
84
Increased
165
Reduced
229
Closed
110

Sector Composition

Rank Sector Weight
1 Technology 28.52%
2 Healthcare 17.53%
3 Financials 13.26%
4 Communication Services 8.82%
5 Consumer Discretionary 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACIW icon
401
ACI Worldwide
ACIW
$5.86B
$760K 0.01%
27,000
-800
-3% -$21.8K
HVT icon
402
Haverty Furniture Companies
HVT
$403M
$760K 0.01%
34,400
LAUR icon
403
Laureate Education
LAUR
$5.38B
$749K 0.01%
48,500
-1,300
-3% -$20K
MEDP icon
404
Medpace
MEDP
$16.1B
$749K 0.01%
12,500
-6,800
-35% -$372K
BAK icon
405
Braskem
BAK
$960M
$748K 0.01%
25,900
-2,900
-10% -$82.4K
AROC icon
406
Archrock
AROC
$6.21B
$736K 0.01%
60,300
-16,500
-21% -$208K
LITE icon
407
Lumentum
LITE
$53.9B
$735K 0.01%
+12,265
New +$734K
OSB
408
DELISTED
Norbord Inc.
OSB
$732K 0.01%
+22,100
New +$864K
CURO
409
DELISTED
CURO Group Holdings Corp.
CURO
$729K ﹤0.01%
+24,100
New +$692K
BIO icon
410
Bio-Rad Laboratories Class A
BIO
$8.74B
$720K ﹤0.01%
2,300
-300
-12% -$93.1K
RFP
411
DELISTED
Resolute Forest Products Inc.
RFP
$711K ﹤0.01%
54,900
-2,300
-4% -$28.8K
BP icon
412
BP
BP
$114B
$710K ﹤0.01%
16,129
+6,673
+71% +$279K
CVG
413
DELISTED
Convergys
CVG
$707K ﹤0.01%
29,800
MYGN icon
414
Myriad Genetics
MYGN
$507M
$699K ﹤0.01%
15,200
-3,900
-20% -$173K
ROCC
415
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$697K ﹤0.01%
8,649
-4,325
-33% -$355K
TIMB icon
416
TIM SA
TIMB
$9.13B
$694K ﹤0.01%
+47,900
New +$745K
EXTN
417
DELISTED
Exterran Corporation
EXTN
$687K ﹤0.01%
25,900
-11,807
-31% -$317K
PAHC icon
418
Phibro Animal Health
PAHC
$1.48B
$686K ﹤0.01%
16,000
PRDO icon
419
Perdoceo Education
PRDO
$2.04B
$675K ﹤0.01%
45,200
-1,700
-4% -$28K
NFLX icon
420
Netflix
NFLX
$305B
$673K ﹤0.01%
+18,000
New +$653K
TECD
421
DELISTED
Tech Data Corp
TECD
$673K ﹤0.01%
9,400
-700
-7% -$56.7K
GES
422
DELISTED
Guess Inc
GES
$658K ﹤0.01%
29,100
EFA icon
423
iShares MSCI EAFE ETF
EFA
$78.5B
$645K ﹤0.01%
9,489
-53,242
-85% -$3.6M
LNTH icon
424
Lantheus
LNTH
$6.58B
$641K ﹤0.01%
42,900
IVR icon
425
Invesco Mortgage Capital
IVR
$759M
$636K ﹤0.01%
4,020

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2018 Portfolio in Review

As of Q3 2018, Grantham, Mayo, Van Otterloo & Co (GMO) held 634 positions worth $14.8B, up 4.8% from $14.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2018 filing shows 84 new, 165 increased, 229 reduced and 110 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 2,337,345 shares worth $107M. The largest sale was Johnson & Johnson, an estimated $132M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q3 2018 buy was Twenty-First Century Fox, Inc. Class B: 2,337,345 shares worth $107M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to iShares MSCI Emerging Markets ETF in Q3 2018, an estimated $167M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $132M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Dell in Q3 2018, selling an estimated $52.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 31% of its $14.8B portfolio in Q3 2018.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 84 new positions and closed 110 in Q3 2018.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 4.8% quarter-over-quarter to $14.8B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2018, filed 14 Nov 2018.